Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POM121 transmembrane nucleoporin like 1, pseudogene (POM121L1P) is classified as an unprocessed pseudogene in humans[2][8][7]. It is homologous to the POM121 family, which encodes components of the nuclear pore complex, but POM121L1P itself is not believed to encode a functional protein. It is located on human chromosome 22 and has high sequence similarity to other chromosomal regions involving POM121 and related long noncoding RNAs, but, as a pseudogene, it is not known to possess any established biological function, gene product, or disease association[2][8][3][7]. No evidence supports its role as a therapeutic target or molecular biomarker, or its direct involvement in drug interaction, cellular function, or disease pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POM121 transmembrane nucleoporin like 1, pseudogene (POM121L1P).